For instance, GCK-MODY patients do not require treatment, whereas HNF1A- and HNF4A-MODY patients can be treated with low dose sulfonylurea and HNF1B-MODY patients require insulin treatment (10–13). This evidence concerns the gene HNF1B and MODY.